Use of EP2 selective receptor agonists in medical treatment

Details for Australian Patent Application No. 2004216898 (hide)

Owner Pfizer Products Inc.

Inventors Paralkar, Vishwas Madhav; Roman, Doina Cosma; Thompson, David Duane; Wright, Timothy Michael; Constan, Alexander Angelo; Keshary, Prakash Raj; Maclean, David Burton

Agent Spruson & Ferguson

Pub. Number AU-A-2004216898

PCT Pub. Number WO2004/078169

Priority 60/451,889 04.03.03 US

Filing date 23 February 2004

Wipo publication date 16 September 2004

International Classifications

A61K 031/185 - Acids

A61P 001/04 Drugs for disorders of the alimentary tract or the digestive system

A61P 027/06 Drugs for disorders of the senses

A61K 031/415 - 1,2-Diazoles

A61K 031/433 - Thiadiazoles

A61P 019/00 Drugs for skeletal disorders

A61P 009/02 Drugs for disorders of the cardiovascular system

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078169 Priority application(s): WO2004/078169

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216900-An accessory for a ball game

2004216892-Dried blood plasma product